US Rheumatologists View Cell Therapy as a Potential Game Changer, with Systemic Sclerosis Emerging as the Most Compelling Indication, According to Spherix Global Insights
New research reveals cautious optimism as physicians weigh transformative potential against safety, access, and the enduring role of biologics and